KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,005,620 | +10.5% | 561,799 | +140.0% | 0.00% | – |
| Q1 2023 | $910,450 | +17.1% | 234,049 | +2.4% | 0.00% | – |
| Q4 2022 | $777,305 | -41.9% | 228,619 | -6.7% | 0.00% | – |
| Q3 2022 | $1,338,000 | +51.0% | 245,134 | +24.9% | 0.00% | – |
| Q2 2022 | $886,000 | -38.8% | 196,342 | 0.0% | 0.00% | – |
| Q1 2022 | $1,447,000 | +11.7% | 196,342 | -2.6% | 0.00% | – |
| Q4 2021 | $1,296,000 | -78.9% | 201,550 | -66.2% | 0.00% | -100.0% |
| Q2 2021 | $6,151,000 | -69.5% | 596,000 | -68.9% | 0.00% | -75.0% |
| Q1 2021 | $20,174,000 | -40.2% | 1,917,768 | -12.0% | 0.00% | -33.3% |
| Q4 2020 | $33,734,000 | +32.6% | 2,179,215 | +25.0% | 0.01% | +20.0% |
| Q3 2020 | $25,443,000 | -10.6% | 1,742,700 | +16.0% | 0.01% | -16.7% |
| Q2 2020 | $28,458,000 | +5.9% | 1,502,501 | +7.4% | 0.01% | -14.3% |
| Q1 2020 | $26,868,000 | +3.2% | 1,398,646 | +2.9% | 0.01% | +40.0% |
| Q4 2019 | $26,046,000 | -53.0% | 1,358,630 | -76.4% | 0.01% | -58.3% |
| Q3 2019 | $55,390,000 | +9.6% | 5,757,671 | -31.8% | 0.01% | +9.1% |
| Q2 2019 | $50,547,000 | +2.6% | 8,438,412 | +0.0% | 0.01% | 0.0% |
| Q1 2019 | $49,275,000 | -36.0% | 8,437,359 | +2.7% | 0.01% | -42.1% |
| Q4 2018 | $76,991,000 | -45.9% | 8,216,781 | -1.8% | 0.02% | -36.7% |
| Q3 2018 | $142,444,000 | +1.4% | 8,364,268 | +1.2% | 0.03% | -3.2% |
| Q2 2018 | $140,449,000 | +53.7% | 8,266,641 | +21.4% | 0.03% | +47.6% |
| Q1 2018 | $91,369,000 | +57.5% | 6,808,383 | +12.7% | 0.02% | +61.5% |
| Q4 2017 | $58,010,000 | -16.0% | 6,042,653 | -3.9% | 0.01% | -18.8% |
| Q3 2017 | $69,046,000 | +25.8% | 6,288,263 | +3.7% | 0.02% | +23.1% |
| Q2 2017 | $54,876,000 | -26.1% | 6,063,605 | +4.9% | 0.01% | -27.8% |
| Q1 2017 | $74,223,000 | +37.9% | 5,780,553 | +0.9% | 0.02% | +28.6% |
| Q4 2016 | $53,828,000 | +29.9% | 5,726,416 | +34.5% | 0.01% | +40.0% |
| Q3 2016 | $41,439,000 | +314.3% | 4,258,985 | +185.7% | 0.01% | +233.3% |
| Q2 2016 | $10,003,000 | -11.7% | 1,490,644 | +17.4% | 0.00% | 0.0% |
| Q1 2016 | $11,323,000 | +392.7% | 1,269,485 | +631.9% | 0.00% | +200.0% |
| Q4 2015 | $2,298,000 | +28.3% | 173,456 | +2.0% | 0.00% | – |
| Q3 2015 | $1,791,000 | -58.7% | 170,018 | +6.7% | 0.00% | -100.0% |
| Q2 2015 | $4,337,000 | -19.4% | 159,406 | -9.4% | 0.00% | 0.0% |
| Q1 2015 | $5,384,000 | -33.5% | 175,886 | -18.7% | 0.00% | -50.0% |
| Q4 2014 | $8,093,000 | -29.4% | 216,244 | -34.1% | 0.00% | -33.3% |
| Q3 2014 | $11,462,000 | -27.2% | 328,026 | -3.0% | 0.00% | -25.0% |
| Q2 2014 | $15,742,000 | +33.1% | 338,172 | -11.7% | 0.00% | +33.3% |
| Q1 2014 | $11,824,000 | +2.1% | 382,787 | -24.2% | 0.00% | 0.0% |
| Q4 2013 | $11,579,000 | – | 505,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |